Last reviewed · How we verify

Regional Block 1: Paravertebral

Jennifer Holder-Murray · Phase 3 active Small molecule

A paravertebral regional anesthetic block that delivers local anesthetic adjacent to the vertebral column to block spinal nerves and provide localized pain relief.

A paravertebral regional anesthetic block that delivers local anesthetic adjacent to the vertebral column to block spinal nerves and provide localized pain relief. Used for Perioperative anesthesia and analgesia for thoracic and abdominal surgical procedures, Postoperative pain management.

At a glance

Generic nameRegional Block 1: Paravertebral
Also known asNerve Block
SponsorJennifer Holder-Murray
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhasePhase 3

Mechanism of action

Paravertebral blocks work by injecting local anesthetic into the paravertebral space, which contains the spinal nerves as they exit the intervertebral foramina. This blocks sensory, motor, and sympathetic nerve transmission in the distribution of those nerves, providing anesthesia or analgesia to the chest wall, abdomen, or other regions depending on the level of injection. The technique is used for perioperative pain management and regional anesthesia during surgical procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: